Indoor Biotechnologies is applying CRISPR gene editing to delete Fel d 1 from cat cells, an approach to creating a hypoallergenic cat.
Indoor Biotechnologies has a suite of SARS-CoV-2 proteins in various expression systems, as well as a rapid whole blood T cell test in development.
Indoor Biotechnologies has recently expanded facilities and commissioned a new and improved Environmental Testing Suite (ETS) in Cardiff, Wales.
Indoor Biotechnologies has designed and created a comprehensive portfolio of allergen components for diagnostic use, including dust mite, animal, food, mold, pollen, cockroach, venom and other allergens.
InBio has completed a study comparing the allergen content of early introduction food (EIF) brands.